Search results
Showing 2056 to 2070 of 7682 results
Evidence-based recommendations on the Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms.
Durvalumab for neoadjuvant and adjuvant treatment of muscle-invasive bladder cancer [ID6168]
Awaiting development [GID-TA11115] Expected publication date: TBC
Awaiting development [GID-TA11365] Expected publication date: TBC
Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
In development [GID-TA11215] Expected publication date: TBC
Evidence-based recommendations on Memokath 051 Ureter stent for ureteric obstruction.
View recommendations for MTG75Show all sections
Evidence-based recommendations on AposHealth for knee osteoarthritis.
View recommendations for MTG76Show all sections
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)
Evidence-based recommendations on Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer.
View recommendations for MTG72Show all sections
Mega Soft Patient Return Electrode for use during monopolar electrosurgery (MTG11)
Evidence-based recommendations on Mega Soft Patient Return Electrode for use during monopolar electrosurgery.
Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain.
Ambu aScope4 Broncho for use in unexpected difficult airways (MTG14)
Evidence-based recommendations on Ambu aScope4 Broncho for use in unexpected difficult airways.
Evidence-based recommendations on 2 adjunctive colposcopy technologies (the DYSIS colposcope with DYSISmap and the ZedScan I) for assessing suspected cervical abnormalities in people having colposcopy
NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. We will review this decision if a stakeholder notifies NICE again of the topic
Show all sections
Sections for DG47
Evidence-based recommendations on the CoaguChek XS system for self-monitoring coagulation status in adults and children. The recommendations originally included the InRatio2 PT/INR, but this was withdrawn from the market in October 2016 and is not currently available
Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)
Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography